Pharmacologic and mechanical strategies for preventing venous thromboembolism after bariatric surgery: A systematic review and meta-analysis

Daniel Brotman, Hasan M. Shihab, Kalpana R. Prakasa, Sosena Kebede, Elliott Haut, Ritu Sharma, Kenneth M Shermock, Yohalakshmi Chelladurai, Sonal Singh, Jodi Segal

Research output: Contribution to journalArticle

Abstract

We sought to assess the comparative effectiveness and safety of pharmacologic and mechanical strategies to prevent venous thromboembolism (VTE) in patients undergoing bariatric surgery. We searched (through August 2012) for primary studies that had at least 2 different interventions. Of 30 902 citations, we identified 8 studies of pharmacologic strategies and 5 studies of filter placement. No studies randomized patients to receive different interventions. One study suggested that low-molecular-weight heparin is more efficacious than unfractionated heparin in preventing VTE (0.25% vs 0.68%, P <.001), with no significant difference in bleeding. One study suggested that prolonged therapy (after discharge) with enoxaparin sodium may prevent VTE better than inpatient treatment only. There was insufficient evidence supporting the hypothesis that filters reduce the risk of pulmonary embolism, with a point estimate suggesting increased rates with filters (pooled relative risk [RR], 1.21 95% CI, 0.57-2.56). There was low-grade evidence that filters are associated with higher mortality (pooled RR, 4.30 95% CI, 1.60-11.54) and higher deep vein thrombosis rates (2.94 1.35-6.38). There was insufficient evidence to support that augmented subcutaneous enoxaparin doses (>40 mg daily or 30 mg twice daily) are more efficacious than standard dosing, with a trend toward increased bleeding. Of note, for both filters and augmented pharmacologic dosing strategies, patients at highest risk for VTE were more likely to receive more intensive interventions, limiting our ability to attribute outcomes to prophylactic strategies used.

Original languageEnglish (US)
Pages (from-to)675-686
Number of pages12
JournalJAMA Surgery
Volume148
Issue number7
DOIs
StatePublished - Jul 2013

Fingerprint

Bariatric Surgery
Venous Thromboembolism
Meta-Analysis
Low Molecular Weight Heparin
Heparin
Hemorrhage
Safety

ASJC Scopus subject areas

  • Surgery

Cite this

Pharmacologic and mechanical strategies for preventing venous thromboembolism after bariatric surgery : A systematic review and meta-analysis. / Brotman, Daniel; Shihab, Hasan M.; Prakasa, Kalpana R.; Kebede, Sosena; Haut, Elliott; Sharma, Ritu; Shermock, Kenneth M; Chelladurai, Yohalakshmi; Singh, Sonal; Segal, Jodi.

In: JAMA Surgery, Vol. 148, No. 7, 07.2013, p. 675-686.

Research output: Contribution to journalArticle

Brotman, Daniel ; Shihab, Hasan M. ; Prakasa, Kalpana R. ; Kebede, Sosena ; Haut, Elliott ; Sharma, Ritu ; Shermock, Kenneth M ; Chelladurai, Yohalakshmi ; Singh, Sonal ; Segal, Jodi. / Pharmacologic and mechanical strategies for preventing venous thromboembolism after bariatric surgery : A systematic review and meta-analysis. In: JAMA Surgery. 2013 ; Vol. 148, No. 7. pp. 675-686.
@article{8c7d9721bc2e49868e26a664db453566,
title = "Pharmacologic and mechanical strategies for preventing venous thromboembolism after bariatric surgery: A systematic review and meta-analysis",
abstract = "We sought to assess the comparative effectiveness and safety of pharmacologic and mechanical strategies to prevent venous thromboembolism (VTE) in patients undergoing bariatric surgery. We searched (through August 2012) for primary studies that had at least 2 different interventions. Of 30 902 citations, we identified 8 studies of pharmacologic strategies and 5 studies of filter placement. No studies randomized patients to receive different interventions. One study suggested that low-molecular-weight heparin is more efficacious than unfractionated heparin in preventing VTE (0.25{\%} vs 0.68{\%}, P <.001), with no significant difference in bleeding. One study suggested that prolonged therapy (after discharge) with enoxaparin sodium may prevent VTE better than inpatient treatment only. There was insufficient evidence supporting the hypothesis that filters reduce the risk of pulmonary embolism, with a point estimate suggesting increased rates with filters (pooled relative risk [RR], 1.21 95{\%} CI, 0.57-2.56). There was low-grade evidence that filters are associated with higher mortality (pooled RR, 4.30 95{\%} CI, 1.60-11.54) and higher deep vein thrombosis rates (2.94 1.35-6.38). There was insufficient evidence to support that augmented subcutaneous enoxaparin doses (>40 mg daily or 30 mg twice daily) are more efficacious than standard dosing, with a trend toward increased bleeding. Of note, for both filters and augmented pharmacologic dosing strategies, patients at highest risk for VTE were more likely to receive more intensive interventions, limiting our ability to attribute outcomes to prophylactic strategies used.",
author = "Daniel Brotman and Shihab, {Hasan M.} and Prakasa, {Kalpana R.} and Sosena Kebede and Elliott Haut and Ritu Sharma and Shermock, {Kenneth M} and Yohalakshmi Chelladurai and Sonal Singh and Jodi Segal",
year = "2013",
month = "7",
doi = "10.1001/jamasurg.2013.72",
language = "English (US)",
volume = "148",
pages = "675--686",
journal = "JAMA Surgery",
issn = "2168-6254",
publisher = "American Medical Association",
number = "7",

}

TY - JOUR

T1 - Pharmacologic and mechanical strategies for preventing venous thromboembolism after bariatric surgery

T2 - A systematic review and meta-analysis

AU - Brotman, Daniel

AU - Shihab, Hasan M.

AU - Prakasa, Kalpana R.

AU - Kebede, Sosena

AU - Haut, Elliott

AU - Sharma, Ritu

AU - Shermock, Kenneth M

AU - Chelladurai, Yohalakshmi

AU - Singh, Sonal

AU - Segal, Jodi

PY - 2013/7

Y1 - 2013/7

N2 - We sought to assess the comparative effectiveness and safety of pharmacologic and mechanical strategies to prevent venous thromboembolism (VTE) in patients undergoing bariatric surgery. We searched (through August 2012) for primary studies that had at least 2 different interventions. Of 30 902 citations, we identified 8 studies of pharmacologic strategies and 5 studies of filter placement. No studies randomized patients to receive different interventions. One study suggested that low-molecular-weight heparin is more efficacious than unfractionated heparin in preventing VTE (0.25% vs 0.68%, P <.001), with no significant difference in bleeding. One study suggested that prolonged therapy (after discharge) with enoxaparin sodium may prevent VTE better than inpatient treatment only. There was insufficient evidence supporting the hypothesis that filters reduce the risk of pulmonary embolism, with a point estimate suggesting increased rates with filters (pooled relative risk [RR], 1.21 95% CI, 0.57-2.56). There was low-grade evidence that filters are associated with higher mortality (pooled RR, 4.30 95% CI, 1.60-11.54) and higher deep vein thrombosis rates (2.94 1.35-6.38). There was insufficient evidence to support that augmented subcutaneous enoxaparin doses (>40 mg daily or 30 mg twice daily) are more efficacious than standard dosing, with a trend toward increased bleeding. Of note, for both filters and augmented pharmacologic dosing strategies, patients at highest risk for VTE were more likely to receive more intensive interventions, limiting our ability to attribute outcomes to prophylactic strategies used.

AB - We sought to assess the comparative effectiveness and safety of pharmacologic and mechanical strategies to prevent venous thromboembolism (VTE) in patients undergoing bariatric surgery. We searched (through August 2012) for primary studies that had at least 2 different interventions. Of 30 902 citations, we identified 8 studies of pharmacologic strategies and 5 studies of filter placement. No studies randomized patients to receive different interventions. One study suggested that low-molecular-weight heparin is more efficacious than unfractionated heparin in preventing VTE (0.25% vs 0.68%, P <.001), with no significant difference in bleeding. One study suggested that prolonged therapy (after discharge) with enoxaparin sodium may prevent VTE better than inpatient treatment only. There was insufficient evidence supporting the hypothesis that filters reduce the risk of pulmonary embolism, with a point estimate suggesting increased rates with filters (pooled relative risk [RR], 1.21 95% CI, 0.57-2.56). There was low-grade evidence that filters are associated with higher mortality (pooled RR, 4.30 95% CI, 1.60-11.54) and higher deep vein thrombosis rates (2.94 1.35-6.38). There was insufficient evidence to support that augmented subcutaneous enoxaparin doses (>40 mg daily or 30 mg twice daily) are more efficacious than standard dosing, with a trend toward increased bleeding. Of note, for both filters and augmented pharmacologic dosing strategies, patients at highest risk for VTE were more likely to receive more intensive interventions, limiting our ability to attribute outcomes to prophylactic strategies used.

UR - http://www.scopus.com/inward/record.url?scp=84880219394&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84880219394&partnerID=8YFLogxK

U2 - 10.1001/jamasurg.2013.72

DO - 10.1001/jamasurg.2013.72

M3 - Article

C2 - 23754086

AN - SCOPUS:84880219394

VL - 148

SP - 675

EP - 686

JO - JAMA Surgery

JF - JAMA Surgery

SN - 2168-6254

IS - 7

ER -